Kaizen Financial Strategies Abb Vie Inc. Transaction History
Kaizen Financial Strategies
- $162 Million
- Q1 2025
A detailed history of Kaizen Financial Strategies transactions in Abb Vie Inc. stock. As of the latest transaction made, Kaizen Financial Strategies holds 4,200 shares of ABBV stock, worth $835,212. This represents 0.54% of its overall portfolio holdings.
Number of Shares
4,200
Previous 4,000
5.0%
Holding current value
$835,212
Previous $710,000
23.8%
% of portfolio
0.54%
Previous 0.43%
Shares
17 transactions
Others Institutions Holding ABBV
# of Institutions
4,253Shares Held
1.27BCall Options Held
16.6MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA174MShares$34.6 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.18 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $352B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...